Cargando…
A single-center experience in use of tocilizumab in COVID-19 pneumonia in India
BACKGROUND: IL-6 receptor antagonist tocilizumab (TCZ) has been used in several reported studies in the treatment of COVID-19 pneumonia and pieces of evidence are still emerging. METHODS: All patients with COVID-19 pneumonia showing features of hyperinflammatory syndrome receiving TCZ at a tertiary...
Autores principales: | Joshi, Aditya, Kumar M, Krishna, Kumar, Abhishek, Nair, Ranjith K., Singh, Jasdeep, Chakrabarti, Ritwik, Kapoor, Rajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313049/ https://www.ncbi.nlm.nih.gov/pubmed/34334897 http://dx.doi.org/10.1016/j.mjafi.2021.05.022 |
Ejemplares similares
-
Diabetes Mellitus and Hypertension Increase Risk of Death in Novel Corona Virus Patients Irrespective of Age: a Prospective Observational Study of Co-morbidities and COVID-19 from India
por: Gupta, Anirban, et al.
Publicado: (2021) -
A Study on the Safety of Percutaneous Tracheostomy in Patients with Severe Acute Respiratory Syndrome Novel Corona Virus 2 (SARS-nCoV2) Infection: A Single-Center Observational Cohort Study in a CoVID Intensive Care Unit
por: Mylavarapu, Krishna Kumar, et al.
Publicado: (2021) -
Clinical Triaging in Cough Clinic Alleviates COVID-19 Overload in Emergency Department in India
por: Nayan, Neelabh, et al.
Publicado: (2021) -
Reinfection or Reactivation of Coronavirus-19 in Patients with Hematologic Malignancies: Case Report Series
por: Kapoor, Rajan, et al.
Publicado: (2021) -
Near-Miss Incidents in Obstetric Patients Admitted to an Intensive Care Unit of a Tertiary Care Center in Eastern India: A Retrospective Cohort Study
por: Krishna Kumar, M, et al.
Publicado: (2021)